BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 25483060)

  • 1. Geroconversion: irreversible step to cellular senescence.
    Blagosklonny MV
    Cell Cycle; 2014; 13(23):3628-35. PubMed ID: 25483060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion.
    Leontieva OV; Blagosklonny MV
    Oncotarget; 2014 Dec; 5(24):12715-27. PubMed ID: 25587030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular senescence: when growth stimulation meets cell cycle arrest.
    Blagosklonny MV
    Aging (Albany NY); 2023 Feb; 15(4):905-913. PubMed ID: 36805938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia suppresses conversion from proliferative arrest to cellular senescence.
    Leontieva OV; Natarajan V; Demidenko ZN; Burdelya LG; Gudkov AV; Blagosklonny MV
    Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13314-8. PubMed ID: 22847439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell senescence, rapamycin and hyperfunction theory of aging.
    Blagosklonny MV
    Cell Cycle; 2022 Jul; 21(14):1456-1467. PubMed ID: 35358003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging.
    Blagosklonny MV
    Aging (Albany NY); 2012 Mar; 4(3):159-65. PubMed ID: 22394614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin, proliferation and geroconversion to senescence.
    Blagosklonny MV
    Cell Cycle; 2018; 17(24):2655-2665. PubMed ID: 30541374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S6K in geroconversion.
    Leontieva OV; Demidenko ZN; Blagosklonny MV
    Cell Cycle; 2013 Oct; 12(20):3249-52. PubMed ID: 24036549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program).
    Leontieva OV; Demidenko ZN; Blagosklonny MV
    Oncotarget; 2015 Sep; 6(27):23238-48. PubMed ID: 26177051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular Senescence: What, Why, and How.
    Regulski MJ
    Wounds; 2017 Jun; 29(6):168-174. PubMed ID: 28682291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of replicative senescence by rapamycin in rodent embryonic cells.
    Pospelova TV; Leontieva OV; Bykova TV; Zubova SG; Pospelov VA; Blagosklonny MV
    Cell Cycle; 2012 Jun; 11(12):2402-7. PubMed ID: 22672902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular senescence and aging: the role of B-MYB.
    Mowla SN; Lam EW; Jat PS
    Aging Cell; 2014 Oct; 13(5):773-9. PubMed ID: 24981831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying Senescence-Associated Phenotypes in Primary Multipotent Mesenchymal Stromal Cell Cultures.
    Nadeau S; Cheng A; Colmegna I; Rodier F
    Methods Mol Biol; 2019; 2045():93-105. PubMed ID: 31020633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular aging beyond cellular senescence: Markers of senescence prior to cell cycle arrest in vitro and in vivo.
    Ogrodnik M
    Aging Cell; 2021 Apr; 20(4):e13338. PubMed ID: 33711211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells.
    Leontieva OV; Lenzo F; Demidenko ZN; Blagosklonny MV
    Cell Cycle; 2012 Dec; 11(24):4642-9. PubMed ID: 23187803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Senescent cells: an emerging target for diseases of ageing.
    Childs BG; Gluscevic M; Baker DJ; Laberge RM; Marquess D; Dananberg J; van Deursen JM
    Nat Rev Drug Discov; 2017 Oct; 16(10):718-735. PubMed ID: 28729727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis reveals novel common genes modulated in both replicative and stress-induced senescence.
    Succoio M; Comegna M; D'Ambrosio C; Scaloni A; Cimino F; Faraonio R
    J Proteomics; 2015 Oct; 128():18-29. PubMed ID: 26206181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gerosuppression by pan-mTOR inhibitors.
    Leontieva OV; Blagosklonny MV
    Aging (Albany NY); 2016 Dec; 8(12):3535-3551. PubMed ID: 28077803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of CIP2A attenuates tumor progression by inducing cell cycle arrest and promoting cellular senescence in hepatocellular carcinoma.
    Yang X; Qu K; Tao J; Yin G; Han S; Liu Q; Sun H
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1807-1814. PubMed ID: 29175329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinated post-transcriptional control of oncogene-induced senescence by UNR/CSDE1.
    Avolio R; Inglés-Ferrándiz M; Ciocia A; Coll O; Bonnin S; Guitart T; Ribó A; Gebauer F
    Cell Rep; 2022 Jan; 38(2):110211. PubMed ID: 35021076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.